Lewy Body Lab

The #Lewybody Lab is based at Newcastle University and is led by Professor @John_PaulTaylor. #DLB #neuroimaging #neuroscience #Alzheimer's #dementia

[NIHR Research Support Service (RSS) @NIHR_RSS]

A general principle of grant writing is that you should give the reader the information that they want when they want it. The idea follows 4 key propositions:
Importance
Success
Value
Competence
Key resource that talks through this idea is The Research Funding Toolkit #RDStips

[VJ Neurology @VJNeurology]

#ADPD2021 is coming up soon! Only a week left 📅

@VJNeurology will be hearing from the expert speakers so head over to 🧠https://t.co/FB5htuqt0q🧠 to get involved!

@adpdnet #Alzheimers #Parkinsons #Neurology #Neuroscience #Alz #EndAlz #MovementDisorders

[Neuroscience News @NeuroscienceNew]

A New Theory for How Memories Are Stored in the Brain

The theory is based on the discovery of the protein molecule, talin, which contains switch-like domains that change shape in response to pressure in mechanical force by a cell.

#neuroscience #science

https://t.co/YxDeRVVJnL

[Neurology Trainees @ABNTrainees]

Great course for those interested in LBD, free and online this year - sign up!

[Lewy Body Society @lbsorg]

We’re delighted to share the programme for the #LewyBodyUK scientific conference on 15th June!

Join us to hear about the latest LBD research.

More details and book: https://t.co/rewqlZryhK

A free online event, open to all including people living with LBD and carers

[Alzheimer's Research UK @AlzResearchUK]

Can we really reduce the number of people living with dementia by 40%? https://t.co/wI1gErmySs

[OPDC (Parkinson's Research) @OxfordPDCentre]

Have a read of the new interview with Professor Caleb Webber, UK DRI at Cardiff & OPDC Investigator. 👇

[British Geriatrics Society @GeriSoc]

The BGS told the @LordsSTCom inquiry about our concerns regarding the long-term impact of the #COVID19 pandemic and the lockdown on older people’s health including 'worsening #frailty'. See the full report here: https://t.co/w0naWr62hI

[British Geriatrics Society @GeriSoc]

#Polypharmacy is an important issue for older people’s healthcare. See BGS members @KeebleM and @OlderTrialsProf comments in @LordsSTCom's new report here https://t.co/w0naWr62hI

[Dementias Platform UK @DementiasUK]

#NewPodcast 🎧

Check out our latest podcast, a discussion with Feyi Raimi-Abraham, CEO of @blackdementiaco, about the experiences of Black people with dementia in the UK and how we can improve diversity in research participants.

Listen here: https://t.co/HHkJ8CHRN2

[Alzforum @alzforum]

RNA-Seq analysis finds three types of #alzheimersdisease, distinguished by different pathologies and molecular drivers. @IcahnMountSinai https://t.co/ZDwEowTVgc

[Royal College of Psychiatrists @rcpsych]

Booking now open for the Faculty of Old Age Psychiatry @rcpsychOldAge Annual Conference, 25-26 March Register now for latest research on dementia, medically unexplained symptoms and how to treat depression in older people. #OAPsych2021
https://t.co/nYpuhodhIX

[Alzheimer's Drug Discovery Foundation @TheADDF]

#ADDFYearInReview Highlight #4:

We reported on the latest finding from the #LancetCommission and launched our #CognitiveVitality Reports, a new resource of over 200 reports for researchers & clinicians evaluating brain supplements, drugs in development, and more.

[Alzheimer's Drug Discovery Foundation @TheADDF]

What is #Shankhpushpi and can it really improve your memory? Head over to #CognitiveVitality to read our latest rating and find out: https://t.co/NDHvtW0RT0

[ADI @AlzDisInt]

In line with new evidence from @TheLancet Commission on #Dementia prevention, intervention & care, ADI is pleased to launch our new infographic on dementia risk factors. Download now: https://t.co/0TVsu4pcbK

[Nat Rev Neurology @NatRevNeurol]

Retinal thickness predicts the risk of cognitive decline in Parkinson's disease https://t.co/fYctjDRZ4K

[NIHR UCLH Biomedical Research Centre @UCLHresearch]

Certain diabetes drugs may reduce Parkinson’s risk

Full story: https://t.co/b1PTVnKmgu

[Toronto Dementia Research Alliance @TorontoDementia]

3/5 These initial positive results led to plans for a larger clinical trial to assess the effects of #nabilone on agitation and brain inflammation, which was awarded @TheADDF’s Advances Clinical Trials Grant of $1.4M USD to move forward: https://t.co/3zQPO2DXQ5

[Nat Rev Neurology @NatRevNeurol]

Impaired metabolic brain networks associated with neurotransmission systems in the a-synuclein spectrum https://t.co/AvCeCb5SHT

[Brain @Brain1878]

Jack et al. identify variables that predict future rates of tau PET accumulation in cognitively impaired and cognitively unimpaired individuals. https://t.co/BXxMf5q6XY